Dedication to advancing the prevention and management of cardiovascular diseases——Professor Ma Changsheng

doi:10.3969/j.issn.1006-7795.2020.05.021

Abstract

CLC Number:

Jia Zhaoxu, Ma Changsheng. Dedication to advancing the prevention and management of cardiovascular diseases——Professor Ma Changsheng[J]. Journal of Capital Medical University, 2020, 41(5): 834-838.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.05.021

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I5/834

[1] Morin D P, Bernard M L, Madias C, et al. The state of the art:atrial fibrillation epidemiology, prevention, and treatment[J]. Mayo Clin Proc,2016,91(12):1778-1810.
[2] Odutayo A, Wong C X, Hsiao A J, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death:systematic review and meta-analysis[J]. BMJ,2016,354:i4482.
[3] Knecht S, Hocini M, Wright M, et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation[J]. Eur Heart J,2008,29(19):2359-2366.
[4] Rostock T, Steven D, Hoffmann B, et al. Chronic atrial fibrillation is a biatrial arrhythmia:data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach[J]. Circ Arrhythm Electrophysiol,2008,1(5):344-353.
[5] Dong J Z, Sang C H, Yu R H, et al. Prospective randomized comparison between a fixed ‘2C3L’ approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation[J]. Europace,2015,17(12):1798-1806.
[6] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace,2016,18(11):1609-1678.
[7] January C T, Wann L S, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol,2019,74(1):104-132.
[8] Du X, Ninomiya T, de Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation:results of the ADVANCE study[J]. Eur Heart J,2009,30(9):1128-1135.
[9] Soliman E Z, Safford M M, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction[J]. JAMA Intern Med,2014,174(1):107-114.
[10] Catapano A L, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias:The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)[J]. Atherosclerosis,2016,253:281-344.
[11] Xia S J, Du X, Li C, et al. Uptake of evidence-based statin therapy among atrial fibrillation patients in China:A report from the CAFR (Chinese Atrial Fibrillation Registry) Study[J]. Int J Cardiol,2016,220:284-289.
[12] Jiang C, Lan D H, Du X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation:A report from the China atrial fibrillation registry study[J]. J Cardiovasc Electrophysiol,2019,30(12):2759-2766.
[13] Chen Y W, Bai R, Lin T, et al. Pacing or ablation:which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?[J]. Pacing Clin Electrophysiol,2014,37(4):403-411.
[14] Du X, Patel A, Anderson C S, et al. Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement:JACC International[J]. J Am Coll Cardiol,2019,73(24):3135-3147.
[15] Du X, Dong J, Ma C. Is atrial fibrillation a preventable disease?[J]. J Am Coll Cardiol,2017,69(15):1968-1982.

Dedication to advancing the prevention and management of cardiovascular diseases——Professor Ma Changsheng

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 12

Recommended Articles

Metrics

Comments

[1]	Zhao Jizong. Current status and clinical research of brain-heart comorbid vascular diseases in China [J]. Journal of Capital Medical University, 2022, 43(5): 671-673.
[2]	Yue Xiaolin, Li Xiaoling, Wang Meixia,Bai Hua, Zhang Zhuoran, Wang Xiangping. Formulation and preliminary application of on-site supervision and inspection scoring standards for mutual recognition of medical ethics review in Beijing [J]. Journal of Capital Medical University, 2022, 43(4): 664-668.
[3]	Yu Ronghui, Tang Ribo, Wu Jiahui, Wen Songnan, Lin Hui. Safety and efficacy of catheter ablation for atrial fibrillation patients with history of renal transplantation [J]. Journal of Capital Medical University, 2020, 41(3): 433-438.
[4]	Zhang Yang, Ma Zhanhong, Jiang Tao. Does the left atrial appendage morphology correlate with the risk of thrombus and transient ischemic attack in patients with atrial fibrillation? [J]. Journal of Capital Medical University, 2019, 40(5): 776-780.
[5]	Cheng Liting, Gao Jiale, Yuan Linhao, Wu Yongquan. Analysis of clinical features and cross-sectional echocardiography of lone atrial fibrillation and non-lone atrial fibrillation patients [J]. Journal of Capital Medical University, 2018, 39(6): 945-949.
[6]	Lin Tao, Wei Xin, Xu Xiaowei, Ma Yan, Wang Rui, Tian Junping, Guo Xiaobin, Chen Buxing. Experience in using a steerable sheath during the pulmonary veins isolation for paroxysmal atrial fibrillation ablation [J]. Journal of Capital Medical University, 2016, 37(1): 54-57.
[7]	Zhang Zhenhua, Zhang Haibo, Han Jiancheng, Meng Xu, Han Jie, Li Yan, Wang Gang. Effect of minimally invasive surgery on left atrial function in atrial fibrillation patients [J]. Journal of Capital Medical University, 2015, 36(3): 371-375.
[8]	Mu Liying;Du Fenghe;Xu Xiuying . Clinical Analysis of Risk Factors for Stroke in Patients with Nonvalvular Atrial Fibrillation [J]. Journal of Capital Medical University, 2006, 27(3): 375-378.
[9]	Li Mei;Hua Qi;Liu Rongkun;Yang Zheng. Effects of Atrial Fibrillation Complicated with Hypertension on Endothelial Function [J]. Journal of Capital Medical University, 2005, 26(3): 312-315.
[10]	Wang Changhua;Hu Dayi;Tang Chuzhong;Wu Mingying;Mei Yunqing . Experimental Research on the Change of Gene Expression of Interleukin-1β, Interleukin-6 and Tumor Necrosis Factor-α in Right Atrial ppendages of Patients with Chronical Atrial Fibrillation [J]. Journal of Capital Medical University, 2005, 26(2): 111-115.
[11]	Sun Yilin;Zhang Hui;Qu Baoqing;Wang Zhongcheng;Zhang Junting. Skull base Chordoma: Ultrastructure and Clinical Research [J]. Journal of Capital Medical University, 2003, 24(1): 60-63.
[12]	Song Ke;Liu Xuanzhong . Intravenous Amiodarone for Fast Atrial Fibrillation in Patients with Acute Myocardial Infarction [J]. Journal of Capital Medical University, 2002, 23(3): 222-224.